insights_auto
Why is SNPHY down 3.41%?
Dive Deeperchevron_right
SNPHY:OTCMKTS
Santen Pharmaceutical ADR Representing Ord Shs
$10.33
arrow_downward
-3.41%(-0.36) 1D
Oct 12, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SNPHY...
Open
$10.18
High
$10.51
Low
$10.18
Mkt. cap
549.06B
Avg. vol.
2.71K
Volume
990.00
52-wk high
$13.92
52-wk low
$9.22
Beta
0.49
Shares outstanding
322.31M
No. of employees
4K
Open
$10.18
High
$10.51
Low
$10.18
Mkt. cap
549.06B
Avg. vol.
2.71K
Volume
990.00
52-wk high
$13.92
52-wk low
$9.22
Beta
0.49
Shares outstanding
322.31M
No. of employees
4K
News stories
From web sources and news partners
TradingView
·
1 hour ago
IXIC: Nasdaq Futures Shed 1% as Chip Selloff in Asia Triggers Trading Halt
Benzinga
·
47 minutes ago
Stock Market: Will S&P 500 Open Up or Down Today?
Trefis
·
44 minutes ago
S&P 500 Movers | Winners: FICO, MDT, ZBH | Losers: CIEN, LITE, COHR
marketscreener.com
·
2 hours ago
S&P 500 index showed little change after Stockholm Stock Exchange close
Profile
Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established. In 2014 Santen announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products. Wikipedia
About Santen Pharmaceutical ADR Representing Ord Shs
CEOAkira Kurokawa | Shigeo Taniuchi
Employees3.97K
Founded1890
HeadquartersOsaka, Kansai, Japan
SectorPharmaceutical industry
Websitesanten.com